Open Access Editorial

Why "Radiation Oncology"

Claus Belka1* and Kevin A Camphausen2

Author Affiliations

1 Department of Radiation Oncology, University Tübingen, Germany

2 National Cancer Institute Bethesda, Radiation Oncology Branch, Bethesda, USA

For all author emails, please log on.

Radiation Oncology 2006, 1:1 doi:10.1186/1748-717X-1-1

Published: 28 February 2006

Abstract

Radiotherapy continues to be a major treatment for solid tumours and is a cornerstone of modern oncology. The term 'radiation oncology' describes the integration of radiation therapy into the complexity of multi-modal therapy. Over the last ten years the crucial role of radiation therapy as part of multi-modality protocols in cancer care has been documented in numerous Phase III trials. Advances in treatment technology as well as the underlying biology of tumour resistance mechanisms will further strengthen the role of radiation oncology. The scientific role of radiation oncology is reflected by the increase in the number of papers related to radiation oncology in resources like Medline. In order to reflect the growing scientific importance of radiation oncology, radiation physics and radiation biology, we have initiated Radiation Oncology as the first open access journal in the field. Open access allows for a rapid and transparent publication process together with an unequalled opportunity to reach the widest reader spectrum possible.